Authors:
Chazette, P
Pelon, J
Moulin, C
Dulac, F
Carrasco, I
Guelle, W
Bousquet, P
Flamant, PH
Citation: P. Chazette et al., Lidar and satellite retrieval of dust aerosols over the Azores during SOFIA/ASTEX, ATMOS ENVIR, 35(25), 2001, pp. 4297-4304
Citation: Gy. Sy et al., Nitric oxide and central antihypertensive drugs - One more difference between catecholamines and imidazolines, HYPERTENSIO, 37(2), 2001, pp. 246-249
Authors:
Schimel, DS
House, JI
Hibbard, KA
Bousquet, P
Ciais, P
Peylin, P
Braswell, BH
Apps, MJ
Baker, D
Bondeau, A
Canadell, J
Churkina, G
Cramer, W
Denning, AS
Field, CB
Friedlingstein, P
Goodale, C
Heimann, M
Houghton, RA
Melillo, JM
Moore, B
Murdiyarso, D
Noble, I
Pacala, SW
Prentice, IC
Raupach, MR
Rayner, PJ
Scholes, RJ
Steffen, WL
Wirth, C
Citation: Ds. Schimel et al., Recent patterns and mechanisms of carbon exchange by terrestrial ecosystems, NATURE, 414(6860), 2001, pp. 169-172
Authors:
Schann, S
Bruban, V
Pompermayer, K
Feldman, J
Pfeiffer, B
Renard, P
Scalbert, E
Bousquet, P
Ehrhardt, JD
Citation: S. Schann et al., Synthesis and biological evaluation of pyrrolinic isosteres of rilmenidine. Discovery of cis-/trans-dicyclopropylmethyl-(4,5-dimethyl-4,5-dihydro-3H-pyrrol-2-yl)-amine (LNP 509), an I-1 imidazoline receptor selective ligand with hypotensive activity, J MED CHEM, 44(10), 2001, pp. 1588-1593
Authors:
Bruban, V
Feldman, J
Greney, H
Dontenwill, M
Schann, S
Jarry, C
Payard, M
Boutin, J
Scalbert, E
Pfeiffer, B
Renard, P
Vanhoutte, P
Bousquet, P
Citation: V. Bruban et al., Respective contributions of alpha-adrenergic and non-adrenergic mechanismsin the hypotensive effect of imidazoline-like drugs, BR J PHARM, 133(2), 2001, pp. 261-266
Citation: P. Bousquet, Identification and characterization of I-1 imidazoline receptors: Their role in blood pressure regulation, AM J HYPERT, 13(6), 2000, pp. 84S-88S
Authors:
Greney, H
Ronde, P
Magnier, C
Maranca, F
Rascente, C
Quaglia, W
Giannella, M
Pigini, M
Brasili, L
Lugnier, C
Bousquet, P
Dontenwill, M
Citation: H. Greney et al., Coupling of I-1 imidazoline receptors to the cAMP pathway: Studies with a highly selective ligand, benazoline, MOLEC PHARM, 57(6), 2000, pp. 1142-1151
Citation: P. Bousquet et J. Feldman, Drugs acting on imidazoline receptors: A review of their pharmacology, their use in blood pressure control and their potential interest in cardioprotection (vol 58, pg 799, 1999), DRUGS, 59(1), 2000, pp. 16-16
Authors:
Bousquet, P
Ciais, P
Peylin, P
Ramonet, M
Monfray, P
Citation: P. Bousquet et al., Inverse modeling of annual atmospheric CO2 sources and sinks 1. Method andcontrol inversion, J GEO RES-A, 104(D21), 1999, pp. 26161-26178
Authors:
Bousquet, P
Peylin, P
Ciais, P
Ramonet, M
Monfray, P
Citation: P. Bousquet et al., Inverse modeling of annual atmospheric CO2 sources and sinks 2. Sensitivity study, J GEO RES-A, 104(D21), 1999, pp. 26179-26193
Authors:
Monassier, L
Riehl, V
Lienhard, JP
Tibirica, E
Feldman, J
Bousquet, P
Citation: L. Monassier et al., Effects of ifenprodil and baclofen on exercise-induced increase of myocardial oxygen demand in normotensive rats, J PHARM EXP, 290(3), 1999, pp. 1188-1194
Authors:
Quaglia, W
Bousquet, P
Pigini, M
Carotti, A
Carrieri, A
Dontenwill, M
Gentili, F
Giannella, M
Maranca, F
Piergentili, A
Brasili, L
Citation: W. Quaglia et al., 2-(2-phenylcyclopropyl) imidazolines: Reversed enantioselective interaction at I-1 and I-2 imidazoline receptors, J MED CHEM, 42(15), 1999, pp. 2737-2740
Citation: P. Bousquet et J. Feldman, Drugs acting on imidazoline receptors - A review of their pharmacology, their use in blood pressure control and their potential interest in cardioprotection, DRUGS, 58(5), 1999, pp. 799-812